VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
← Pulse/Companies/Index Ventures

Index Ventures Valuation & Funding

Venture Capital

Index Ventures is a global venture capital firm backing founders from seed through growth stage across enterprise software, fintech, consumer, AI, and life sciences.

2
Stories

Last updated: Jul 23, 2026

Company Profile

Index Ventures is a global venture capital firm backing founders from seed through growth stage across enterprise software, fintech, consumer, AI, and life sciences.

Founded 1996London, United Kingdom
See every investor we track →Everything connected to Index Ventures →
Compare with
vs GVvs Andreessen Horowitzvs Kleiner Perkinsvs Khosla Venturesvs Menlo Venturesvs Emergence Capitalvs Mayfieldvs Aramco Venturesvs Seedcampvs Y Combinatorvs Spark Capitalvs Third Point Venturesvs Accelvs Dell Technologies Capitalvs Tapestry VCvs Lux Capitalvs Theory Ventures
Related dashboards
VC Fund Performance →Funding Rounds Guide →

Index Ventures FAQ

Is Index Ventures publicly traded?
No. Index Ventures is privately held.

Coverage Timeline

newest first
  1. Jul 23, 2026FUNDINGFomo Raises $75M Series B for Consumer Crypto Trading$75M Series B→
  2. Jul 17, 2026FUNDINGChai Discovery Raises $400M at $3.8B for AI Drug Design$400M at $3.8B→

All Coverage

FUNDING· Jul 22, 2026

Fomo Raises $75M Series B for Consumer Crypto Trading

Illustration for: Fomo Raises $75M Series B for Consumer Crypto Trading
FUNDING$75M Series B

Fomo Raises $75M Series B for Consumer Crypto Trading

Consumer crypto trading app Fomo raised a $75 million Series B led by Index Ventures at a $550 million valuation, adding equities and prediction markets after its first year saw $4 billion in trading volume.

Jul 22, 2026
FUNDING· Jul 17, 2026

Chai Discovery Raises $400M at $3.8B for AI Drug Design

Illustration for: Chai Discovery Raises $400M at $3.8B for AI Drug Design
FUNDING$400M at $3.8B

Chai Discovery Raises $400M at $3.8B for AI Drug Design

Life-sciences AI startup Chai Discovery raised a $400 million Series C at a $3.8 billion valuation led by Index Ventures, Sequoia, Dimension and Kleiner Perkins, one of the largest rounds yet for AI-driven drug and molecule design.

Jul 17, 2026
@Trace_Cohen·t@nyvp.com